25-207
RESOLUTION AUTHORIZING LITIGATION AGAINST MAJOR INSULIN MANUFACTURERS, GLP-1 MANUFACTURERS, AND PHARMACY BENEFIT MANAGERS FOR DAMAGES ASSOCIATED WITH ARTIFICIAL INFLATION OF PRICING FOR DIABETIC AND WEIGHT-LOSS MEDICATIONS, AND QUALIFYING AND RETAINING FRANTZ LAW GROUP, APLC TO PROVIDE OUTSIDE LEGAL SERVICES RELATED TO SAME, PURSUANT TO N.J.S.A. 40A:11-5, ET SEQ.
- Committee
- Administration and Finance
- Requested by
- County Counsel
- Introduced
- March 5, 2025
- On agenda
- March 11, 2025
- Passed
- March 11, 2025
- Enacted
- March 11, 2025
- Enactment no.
- R-25-190